Therapy News and Research

RSS

AMS agrees to sell Gamma Knife and radiation therapy services business in Turkey to Euromedic

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, announced today that it has entered into an agreement to sell its Gamma Knife and radiation therapy services business in Turkey to Euromedic Cancer Treatment Centers BV.

4 Jun 2014

Leukemia researcher wins 2014 Taubman Prize for Excellence in Translational Medical Science

A physician-scientist who developed a personalized immunotherapy for leukemia using patients' own T cells is the recipient of the 2014 Taubman Prize for Excellence in Translational Medical Science, awarded by the A. Alfred Taubman Medical Research Institute at the University of Michigan Medical School.

4 Jun 2014

New app for smartphones automatically calculates carbohydrate content of meal

An app for smartphones automatically calculates the carbohydrate content of a meal. The programme called "GoCARB" enables diabetics to better plan their meals and to control their blood glucose easier.

4 Jun 2014

2014 PAINWeekEnd Regional Conference to be held in Tarrytown, NY

There are 116 million people in pain. There are 4,000 pain specialists. That's 29,000 patients per pain specialist. There are simply not enough pain specialists to go around.

4 Jun 2014

AFFiRiS releases positive study results of AD04 therapeutic drug in Alzheimer patients

AFFiRiS announced today the results of a phase II study in Alzheimer patients. AFFiRiS' proprietary compound AD04 is the first drug ever to demonstrate clinical and biomarker effects consistent with disease modification in Alzheimer patients.

4 Jun 2014

New nanomedicine allows glaucoma patients to do away with daily eye drops

Scientists from Nanyang Technological University (NTU) and the Singapore Eye Research Institute (SERI) have jointly developed a new nanomedicine that will allow glaucoma patients to do away with daily eye drops.

4 Jun 2014

Incyte’s ruxolitinib Phase III study for polycythemia vera achieves primary endpoint

Incyte Corporation (Nasdaq: INCY) today announced results from the RESPONSE trial, the first pivotal Phase III study evaluating a JAK1/JAK2 inhibitor for the treatment of polycythemia vera (PV).

4 Jun 2014

Delays in receiving TAVR for severe aortic stenosis could impact effectiveness of treatment

Severe aortic stenosis (AS) has a grave prognosis with 25-50% of patients dying within a year once symptoms develop. Transcatheter aortic valve replacement (TAVR) represents a paradigm shift in the therapeutic options for these patients.

4 Jun 2014

New technology can non-invasively image human lymphatic system

The human lymphatic system is an important but poorly understood circulatory system consisting of tiny vessels spread throughout the body.

4 Jun 2014

New process to help select personalized treatment options for patients with lung adenocarcinoma

Moffitt Cancer Center researchers, in collaboration with the Lung Cancer Mutation Consortium, have developed a process to analyze mutated genes in lung adenocarcinoma to help better select personalized treatment options for patients.

4 Jun 2014

Implantable cardioverter defibrillators improve survival among heart failure patients

Implantable cardioverter defibrillators (ICDs) are associated with improved survival among heart failure patients whose left ventricles only pump 30 to 35 percent of blood out of the heart with each contraction, according to a study from the Duke Clinical Research Institute.

4 Jun 2014

EC approves extension of INVEGA antipsychotic drug to include adolescents aged 15 years and older

Janssen-Cilag International NV announced today that the European Commission has approved an extension of the oral atypical antipsychotic INVEGA® (paliperidone ER) schizophrenia indication, to include adolescents aged 15 years and older.

4 Jun 2014

European researchers explore new tools for prevention of back pain

European researchers and clinicians are working hand in hand to unveil the mechanisms leading to back pain, likely the most widespread chronic pathology among humans. Until recently, it was assumed that disc degeneration was the main process behind back pain. The intervertebral discs are joints made of soft and very strain resistant material, placed between the vertebrae of the spine.

4 Jun 2014

UIC conducts clinical trial to evaluate three-drug combination therapy for advanced pancreatic cancer

Researchers at the University of Illinois at Chicago are conducting a clinical trial to evaluate a new, three-drug combination therapy for advanced pancreatic cancer.

4 Jun 2014

Polyarticular juvenile idiopathic arthritis (PJIA): an interview with Dr. Kramer, VP, Immunology and Infectious Diseases Medical Unit, Genentech

Polyarticular Juvenile Idiopathic Arthritis (PJIA) is a type of Juvenile Idiopathic Arthritis (JIA), a group of Rheumatoid Arthritis (RA) diseases that manifests in multiple ways in children.

3 Jun 2014

Teva Pharmaceutical Industries enters into definitive agreement to acquire Labrys

Teva Pharmaceutical Industries Ltd., and Labrys Biologics, Inc., a privately-held development stage biotechnology company focused on treatments for chronic migraine and episodic migraine, today announced that Teva has entered into a definitive agreement to acquire Labrys, broadening Teva's array of biotechnology assets and capabilities.

3 Jun 2014

Lung cancer patient's blood sample can help predict treatment response

Scientists have shown how a lung cancer patient's blood sample could be used to monitor and predict their response to treatment - paving the way for personalised medicine for the disease.

3 Jun 2014

Eventual drug resistance prevents long-term cure in most patients with metastatic melanoma

A study by scientists in Manchester has shown how melanoma drugs can cause the cancer to progress once a patient has stopped responding to treatment.

3 Jun 2014

Duke researchers identify first piece of new brain-repair circuit

Duke researchers have found a new type of neuron in the adult brain that is capable of telling stem cells to make more new neurons. Though the experiments are in their early stages, the finding opens the tantalizing possibility that the brain may be able to repair itself from within.

3 Jun 2014

New research on innovative immunotherapies for melanoma, cervical cancer presented at ASCO 2014

New research on innovative immunotherapies for advanced or high-risk melanoma and cervical cancer were presented today at the 50th Annual Meeting of the American Society of Clinical Oncology.

3 Jun 2014

Therapy News and Research

AMS agrees to sell Gamma Knife and radiation therapy services business in Turkey to Euromedic

Leukemia researcher wins 2014 Taubman Prize for Excellence in Translational Medical Science

New app for smartphones automatically calculates carbohydrate content of meal

2014 PAINWeekEnd Regional Conference to be held in Tarrytown, NY

AFFiRiS releases positive study results of AD04 therapeutic drug in Alzheimer patients

New nanomedicine allows glaucoma patients to do away with daily eye drops

Incyte’s ruxolitinib Phase III study for polycythemia vera achieves primary endpoint

Delays in receiving TAVR for severe aortic stenosis could impact effectiveness of treatment

New technology can non-invasively image human lymphatic system

New process to help select personalized treatment options for patients with lung adenocarcinoma

Implantable cardioverter defibrillators improve survival among heart failure patients

EC approves extension of INVEGA antipsychotic drug to include adolescents aged 15 years and older

European researchers explore new tools for prevention of back pain

UIC conducts clinical trial to evaluate three-drug combination therapy for advanced pancreatic cancer

Polyarticular juvenile idiopathic arthritis (PJIA): an interview with Dr. Kramer, VP, Immunology and Infectious Diseases Medical Unit, Genentech

Teva Pharmaceutical Industries enters into definitive agreement to acquire Labrys

Lung cancer patient's blood sample can help predict treatment response

Eventual drug resistance prevents long-term cure in most patients with metastatic melanoma

Duke researchers identify first piece of new brain-repair circuit

New research on innovative immunotherapies for melanoma, cervical cancer presented at ASCO 2014

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News